Literature DB >> 12407150

Cytoprotective effects of hyaluronic acid and Carbomer 934P in ocular surface epithelial cells.

Caroline Debbasch1, Stéphanie Bruneau De La Salle, Françoise Brignole, Patrice Rat, Jean-Michel Warnet, Christophe Baudouin.   

Abstract

PURPOSE: To investigate in vitro the cell toxicity and antioxidant effects of two major tear substitutes, hyaluronic acid and a widely used carbomer, with and without preservative.
METHODS: Chang conjunctival cells were treated with different concentrations of unpreserved or preserved carbomer 934P (0.03% and 0.3%), unpreserved or preserved hyaluronic acid (0.018% and 0.18%), and benzalkonium chloride (BAC 0.0005% and 0.005%) for 15 minutes or for 15 minutes with 24 hours of cell recovery, according to previously validated methods. Microplate cold light cytofluorometry was performed to evaluate cell viability (neutral red test), chromatin condensation (Hoechst 33342 test), and reactive oxygen species (ROS) production (dichlorofluorescein diacetate and hydroethidine tests). Confocal microscopy was used to explore morphologic changes.
RESULTS: No alterations were found with unpreserved and preserved hyaluronic acid at all concentrations and times tested. A decrease in cell viability with chromatin condensation appeared with 0.3% preserved carbomer 934P at the two times tested. This cytotoxicity, however, was significantly less than that observed with BAC alone, although the same concentrations of preservative were used. Unpreserved carbomer 934P induced no modification of cell viability after 15 minutes but a significant decrease in chromatin condensation, reversible after 24 hours of cell recovery, when a delayed decrease in cell viability was observed. Production of reactive oxygen species (ROS) decreased with the four formulations of tear substitutes tested at their usual concentrations, whereas a significant production of ROS occurred with BAC.
CONCLUSIONS: These two ophthalmic hydrogels have no cytotoxicity but possess antioxidant properties and tend to reduce the toxic effects of preservatives. These results may allow use of hydrogels, not only in dry eye but also in ocular surface disorders involving oxidative stress and in ophthalmic drug therapy to improve ocular tolerance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12407150

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  21 in total

1.  Evaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15 % and vitamin B12 eye drops.

Authors:  Angelo Macri; Chiara Scanarotti; Anna Maria Bassi; Sebastiano Giuffrida; Giorgio Sangalli; Carlo Enrico Traverso; Michele Iester
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-16       Impact factor: 3.117

Review 2.  [Dry eye. An update on epidemiology, diagnosis, therapy and new concepts].

Authors:  F Schirra; K W Ruprecht
Journal:  Ophthalmologe       Date:  2004-01       Impact factor: 1.059

3.  Cytotoxicity assays of new artificial tears containing 2-methacryloyloxyethyl phosphorylcholine polymer for ocular surface cells.

Authors:  Masahiko Ayaki; Atsuo Iwasawa; Yoshimi Niwano
Journal:  Jpn J Ophthalmol       Date:  2011-08-10       Impact factor: 2.447

4.  Iodide iontophoresis as a treatment for dry eye syndrome.

Authors:  J Horwath-Winter; O Schmut; E-M Haller-Schober; A Gruber; G Rieger
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

5.  New Classes of Polycationic Compounds as Preservatives for Ophthalmic Formulations.

Authors:  Dörte von Deylen; Christina Dreher; Oliver Seidelmann; Stephan Reichl
Journal:  Pharm Res       Date:  2018-11-08       Impact factor: 4.200

6.  Comparative study of topical anti-allergic eye drops on human conjunctiva-derived cells: responses to histamine and IFN gamma and toxicological profiles.

Authors:  Aude Pauly; Françoise Brignole-Baudouin; Jean-Marc Guenoun; Luisa Riancho; Patrice Rat; Jean-Michel Warnet; Christophe Baudouin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-10       Impact factor: 3.117

7.  Iodide protection from UVB irradiation-induced degradation of hyaluronate and against UVB-damage of human conjunctival fibroblasts.

Authors:  Otto Schmut; Jutta Horwath-Winter; Gebhard Rieger; Rudolf Winkler; Gabriele Trummer; Helga Spitzenberger; Christa Wachswender
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-16       Impact factor: 3.117

8.  Comparison of gene expression profiles of conjunctival cell lines with primary cultured conjunctival epithelial cells and human conjunctival tissue.

Authors:  Louis Tong; Yolanda Diebold; Margarita Calonge; Jianping Gao; Michael E Stern; Roger W Beuerman
Journal:  Gene Expr       Date:  2009

9.  In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis).

Authors:  Christophe Baudouin; Alexandre Denoyer; Nicolas Desbenoit; Gregory Hamm; Alice Grise
Journal:  Trans Am Ophthalmol Soc       Date:  2012-12

10.  Genoprotective effect of hyaluronic acid against benzalkonium chloride-induced DNA damage in human corneal epithelial cells.

Authors:  Han Wu; Huina Zhang; Changjun Wang; Yihua Wu; Jiajun Xie; Xiuming Jin; Jun Yang; Juan Ye
Journal:  Mol Vis       Date:  2011-12-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.